Aspen Aerogels, Inc.
NYSE:ASPNConstruction
+$0.24 today
- Market cap
- $407.33M
- Beta
- 2.99
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$1.35
Volume 1.17M
Average 1.58M
ASPN EPS (Basic)
Net income attributable to common shareholders divided by the weighted average basic shares outstanding.
Aspen Aerogels, Inc.NYSE: ASPN
EPS (Basic) · Q1 FY2026 · quarter ended Mar 2026
EPS (Basic) remains negative
Q1 FY2026 EPS (Basic) was -$0.29, compared with -$3.67 a year earlier. Trailing-twelve-month EPS (Basic) was -$1.36.
Context
- EPS (Basic) increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Basic) reaches the consensus estimate from 3 analysts of -$0.77 (+83.7%) for the fiscal year ending Dec 2026, a step up from the -2888.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$0.29+67.0% QoQ
- Last fiscal yearDec 2025
- -$4.74-2888.2% YoY
- LTMMar 2026
- -$1.36+60.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +92.1% | -106.8% | -198.9 pp |
| 1 year | -2888.2% | +83.7% | +2972.0 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Basic) history
USD · from the income statement
- Latest · FY2025
- (4.74) USD
- Year-over-year change
- -2888.2%
| Period | Period end | EPS (Basic) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (4.74) | -2888.2% |
| FY2024 | 2024-12-31 | 0.17 | +125.8% |
| FY2023 | 2023-12-31 | (0.66) | +69.9% |
| FY2022 | 2022-12-31 | (2.19) | -138.0% |
| FY2021 | 2021-12-31 | (0.92) | — |
EPS (Basic) vs competitors
How ASPN compares with its peers on the latest reported figures
- Peers report in different currencies, so EPS (Basic) is compared through growth and rates rather than absolute size.
- Its year-over-year change of +60.9% is the highest of 10, against a peer median of -109.3%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Feb 2026 | $2.54 USD | -34.9% | -18.7% | |
| LTM Mar 2026 | -$0.38 USD | -109.3% | — | |
| LTM Apr 2026 | -$0.51 USD | -111.4% | -90.4% | |
| LTM Mar 2026 | -$0.74 USD | +14.9% | — | |
| FY2025 | -€0.94 EUR | +50.8% | — | |
| LTM Mar 2026 | -$1.36 USD | +60.9% | — | |
| LTM Mar 2026 | -$4.47 USD | -252.0% | — | |
| LTM Apr 2026 | -$5.54 USD | -1038.4% | — | |
| LTM Mar 2026 | -$5.59 USD | -198.4% | — | |
| LTM Mar 2026 | -CN¥7.5 CNY | -40.4% | — | |
| Peer median (excluding ASPN) | — | -109.3% | -54.6% | |
Competitors are the stored peer set for ASPN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 121.62M | 180.36M | 238.72M | 452.7M | 271.1M |
| Cost of Revenue | 111.69M | 175.39M | 181.8M | 269.8M | 225.11M |
| Gross Profit | 9.94M | 4.98M | 56.92M | 182.9M | 46M |
| Gross Margin | 8.2% | 2.8% | 23.8% | 40.4% | 17.0% |
| Research & Development | 11.44M | 16.93M | 16.36M | 18.05M | 6.3B |
| Selling, General & Admin | 39.1M | 67.29M | 89.77M | 106.8M | 40.91B |
| Operating Expenses | 50.54M | 84.22M | 106.12M | 128.36M | 97.39M |
| Depreciation & Amortization | 9.44M | 9.22M | 18.18M | 24.41M | 45.16M |
| EBITDA | (27.43M) | (68.41M) | (22.31M) | 51.46M | 5.72B |
| EBITDA Margin | -22.5% | -37.9% | -9.3% | 11.4% | 2108.3% |
| Operating Income | (40.6M) | (79.25M) | (49.2M) | 54.54M | (51.39M) |
| Operating Margin | -33.4% | -43.9% | -20.6% | 12.0% | -19.0% |
| Interest Income | 0 | 1.62M | 6.53M | 0 | 0 |
| Interest Expense | 229K | 5.11M | 5.33M | 11.96M | 6.06B |
| Other Income / Expenses | 3.51M | (3.49M) | 3.39M | (39.45M) | (335.77M) |
| Income Before Tax | (37.09M) | (82.74M) | (45.81M) | 15.09M | (387.16M) |
| Pre-Tax Margin | -30.5% | -45.9% | -19.2% | 3.3% | -142.8% |
| Income Tax Expense | 0 | 0 | 0 | 1.71M | 2.39M |
| Net Income | (37.09M) | (82.74M) | (45.81M) | 13.38M | (389.55M) |
| Net Margin | -30.5% | -45.9% | -19.2% | 3.0% | -143.7% |
| EPS (Basic) | (0.92) | (2.19) | (0.66) | 0.17 | (4.74) |
| EPS (Diluted) | (0.92) | (2.19) | (0.66) | 0.17 | (4.74) |
| Weighted Avg Shares | 30.43M | 39.36M | 69.44M | 77.54M | 82.66M |
| Weighted Avg Shares (Diluted) | 30.43M | 39.36M | 69.44M | 80.31M | 82.66M |
Aspen Aerogels, Inc.
NYSE:ASPN
Intrinsic Alpha fair value
Locked
Current Price
$4.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.